 |
Previous Article | Next Article 
The Journal of Neuroscience, October 1, 2001, 21(19):7764-7769
Genetic Comparison of Seizure Control by Norepinephrine and
Neuropeptide Y
David
Weinshenker1, 2,
Patricia
Szot3, 4,
Nicole S.
Miller1, 2,
Nicole C.
Rust1, 2,
John G.
Hohmann5,
Ujwal
Pyati2,
Sylvia S.
White3, 4, and
Richard D.
Palmiter1, 2
Departments of 1 Howard Hughes Medical Institute,
2 Biochemistry, 3 Psychiatry and Behavioral
Science, 4 Geriatric Research, Education, and Clinical
Center, and 5 Program for Neurobiology and Behavior,
University of Washington, Seattle, Washington 98195
Epilepsy is a disease of neuronal hyperexcitability, and
pharmacological and genetic studies have identified norepinephrine (NE)
and neuropeptide Y (NPY) as important endogenous regulators of neuronal
excitability. Both transmitters signal through G-protein-coupled receptors, are expressed either together or separately, and are abundant in brain regions implicated in seizure generation. NPY knock-out (NPY KO) and dopamine -hydroxylase knock-out (DBH KO) mice
that lack NE are susceptible to seizures, and agonists of NE and NPY
receptors protect against seizures. To examine the relative
contributions of NE and NPY to neuronal excitability, we tested
Dbh;Npy double knock-out (DKO) mice for seizure sensitivity. In general, DBH KO mice were much more seizure-sensitive than NPY KO
mice and had normal NPY expression, demonstrating that an NPY
deficiency did not contribute to the DBH KO seizure phenotype. DKO mice
were only slightly more sensitive than DBH KO mice to seizures induced
by kainic acid, pentylenetetrazole, or flurothyl, although DKO
mice were uniquely prone to handling-induced seizures. NPY contributed
to the seizure phenotype of DKO mice at high doses of convulsant agents
and advanced stages of seizures. These data suggest that NE is a more
potent endogenous anticonvulsant than NPY, and that NPY has the
greatest contribution under conditions of extreme neuronal excitability.
Key words:
norepinephrine; NPY; dopamine -hydroxylase; mice; epilepsy; seizure; pentylenetetrazole; flurothyl; kainic acid; mice; knock-out; in situ hybridization; neurotransmitter
Copyright © 2001 Society for Neuroscience 0270-6474/01/21197764-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
V. A. Ledoux, T. Smejkalova, R. M. May, B. M. Cooke, and C. S. Woolley
Estradiol Facilitates the Release of Neuropeptide Y to Suppress Hippocampus-Dependent Seizures
J. Neurosci.,
February 4, 2009;
29(5):
1457 - 1468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Aydin, A. Serdaroglu, C. Okuyaz, A. Bideci, and K. Gucuyener
Serum Insulin, Leptin, and Neuropeptide Y Levels in Epileptic Children Treated With Valproate
J Child Neurol,
October 1, 2005;
20(10):
848 - 851.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Cryan, O. F. O'Leary, S.-H. Jin, J. C. Friedland, M. Ouyang, B. R. Hirsch, M. E. Page, A. Dalvi, S. A. Thomas, and I. Lucki
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
PNAS,
May 25, 2004;
101(21):
8186 - 8191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Richichi, E.-J. D. Lin, D. Stefanin, D. Colella, T. Ravizza, G. Grignaschi, P. Veglianese, G. Sperk, M. J. During, and A. Vezzani
Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus
J. Neurosci.,
March 24, 2004;
24(12):
3051 - 3059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bregola, S. Zucchini, D. Rodi, A. Binaschi, C. D'Addario, D. Landuzzi, R. Reinscheid, S. Candeletti, P. Romualdi, and M. Simonato
Involvement of the Neuropeptide Nociceptin/Orphanin FQ in Kainate Seizures
J. Neurosci.,
November 15, 2002;
22(22):
10030 - 10038.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|